Cognitive Evoked Potentials – the P300 Wave in Patients with Sclerosis Multiplex: Relation to the Form of the Disease, Somatic Affection and Quality of Life

Česká verzia

Authors: J. Szilasiová; Z. Novosadová; Z. Gdovinová
Authors place of work: Neurologická klinika LF UPJŠ a FN L. Pasteura, Košice, Slovenská republika
Published in the journal: Cesk Slov Neurol N 2007; 70/103(6): 665-673
Category: Original Paper

Summary

Introduction:
Cognitive function disorders are detected in approximately 65 % of multiple sclerosis (MS) patients. Auditory cognitive evoked potentials (ERP), especially the P300 wave, are an objective electrophysiological indicator of cognitive functions. The objective of the study was to detect cognitive disorders in patients with MS with the use of auditive cognitive evoked potentials, and to compare the disorders with patient demographic and clinical data.

Patient group and method:
The authors of the study examined 110 patients with a definitive MS diagnosis (60 with relapsing/remittent, 41 with secondary progressive and 9 with primary progressive form of MS), and 130 persons from a control group. ERP results were compared with the degree of functional disability measured on the Kurtzke EDSS (Expanded Disability Status Scale), with the degree of cognitive disorders in psychometric tests, the degree of pathological fatigue, depression, and with the patients’ quality of life.

Outcome:
The latencies of the N200 and P300 waves were pathologically prolonged in 69 % of cases as compared with the controls; a higher value of the P300 wave amplitude was detected. Prolonged P300 wave latency highly correlated with cognitive disorders in the psychomotor test (Grassi test), the EDSS score and the quality of life. Low correlations were detected with the patient's age, duration of the disease, degree of EDSS, and the Mini-Mental-State-Examination and IQ scores (evaluated by Raven's progressive matrices). The cognitive deficit did not correlate with the degree of depression in the patients. Patients with progressive forms (primarily and secondarily progressive) showed a higher cognitive deficit as compared with the relapse/remittent form of the disease.

Conclusion:
The rate of incidence of cognitive deficit in our patient group was 69 %. It was related to pathological fatigue and had a negative impact on patients' quality of life. The deficit was more marked in the progressive forms of MS and grew in the course of the disease. Auditive cognitive evoked potentials, the P300 wave, are a suitable method of examining and monitoring cognitive disorders in multiple sclerosis.

Key words:
multiple sclerosis – cognitive disorders – cognitive evoked potentials – P300 wave – quality of life

Zdroje

1. Havrdová E, Bojar M, Čechová Z, Doležil D, Fraňková V, Marečková H a kol. Neuroimunologie. Praha: Maxdorf 2001.

2. LaRocca NG. Cognitive and Emotional Disorders. In: Burks S, Johnson KP, editors. Multiple Sclerosis. Diagnosis, Medical Management, and Rehabilitation. New York: Demos 2000: 405.

3. Honig LS, Ramsay RE, Sheremata WA. Event-related potential P300 in multiple sclerosis. Arch Neurol 1992; 49: 44-50.

4. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 227-231.

5. Kurtzke RF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33: 1444-1452.

6. Folstein MF, Folstein SE, McHugh PR. Mini Mental State. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198.

7. Raven JC. Guide to the Standard Progressive Matrices. London: H.K. Lewis 1960.

8. Repáň Ľ. Ravenova skúška pre dospelých. Bratislava: Psychodiagnostika 1968.

9. Říčan P. Ravenova skouška pro dospělé. Příručka. Bratislava: Psychodiagnostické a didaktické testy 1997.

10. Koubek K, Roušalová V. Grassiho test organicity. Příručka. Bratislava: Psychodiagnostické testy 1986.

11. Bender L. Instructions for the use of visual motor Gestalt test. New York, Am Orthopsychiat Assoc,1946. Bratislava: Psychodiagnostika 1974.

12. Piotrowski C. A Review of the Clinical and Research Use of the Bender-Gestalt test. Perceptual Motor Skills 1995; 81: 1271-1274.

13. Zung WWK. Self-rating Depression Scale. Archives of General Psychiatry 1965; 12: 63-70.

14. Zung WWK. A cross-cultural survey of depressive-symptomatology in normal adults. J Cross-Cult Psychol1972; 3: 177-183.

15. Chalder T, Berelowitz G, Pawlikowska T, Watts L, Wessely S, Wright D et al. Development of a fatigue scale. J Psychosom Res 1993; 37: 147-153.

16. Krupp LB, Sliwinski M, Masur DM, Friedberg F, Coyle PK. Cognitive functioning and depression in patients with chronic fatigue syndrome and multiple sclerosis. Arch Neurol 1994; 51: 705-710.

17. Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The Fatigue Severity Scale: Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 1989; 46: 1121-1123.

18. Schag CC, Heinrich RL, Ganz PA. Karnofsky performance status revisited: Reliability, validity and guidelines. J Clin oncology 1984; 2: 187-193.

19. Crooks V, Waller S, Smith T, Hahn TJ. The use of the Karnofsky Performance Scale in determining outcomes and risk in geriatric outpatients. J Gerontol 1991; 46: 139-144.

20. Suurmeijer A, Doeglas DM, Moum T, Briancon S, Krol B, Sanderman R et al. The Groningen Activity Restriction Scale for measuring disability: its utility in international comparisons. Am J Public Health 1994; 84: 1270-1273.

21. Comi G, Filippi M, Martinelli V, Sirabian G, Visciani A, Campi A et al. Brain magnetic resonance imaging correlates of cognitive impairment in multiple sclerosis. J Neurol Sci 1993; 115 (Suppl): 66-73.

22. Comi G, Filippi M, Martinelli V, Campi A, Rodegher M, Alberoni M et al. Brain MRI correlates of cognitive impairment in primary and secondary progressive multiple sclerosis. J Neurol Sci 1995; 132: 222-2227.

23. Filippi M, Tortorella C, Rovaris M, Bozzali M, Possa F, Sormani MP et al. Changes in the normal appearing brain tissue and cognitive impairment in multiple sclerosis. J Neurol Neurosurg Psychiatry 2000; 60: 157-161.

24. Pozilli C, Passafiume D, Bernardi S, Pantano P, Incoccia C, Bastianello S et al. SPECT, MRI and cognitive function in multiple sclerosis patients. J Neurol Neurosurg Psychiatry 1991; 54: 110-15.

25. Rao SM, Leo GJ, Haughton VM, St. Aubin-Faubert P, Bernardin L. Correlation of magnetic resonance imaging with neuropsychological testing in multiple sclerosis. Neurology 1989; 39: 161-166.

26. Rovaris M, Filippi M, Falautano M, Minicucci L, Rocca MA, Martinelli V et al. Relation between MR abnormalities and patterns of cognitive impairment in multiple sclerosis. Neurology 1998; 50: 1601-1608.

27. Ryan L, Clark CM, Klonoff H, Li D, Paty D. Patterns of cognitive impairment in relapsing-remitting multiple sclerosis and their relationship to neuropathology on magnetic resonance images. Neuropsychology 1996; 10: 176-193.

28. Aminoff JC, Goodin DS. Long-latency cerebral event-related potentials in multiple sclerosis. J Clin Neurophysiol 2001; 18: 372-377.

29. Ellger T, Bethke F, Frese A, Luettmann RJ, Buchheister A, Ringelstein EB, Evers S. Event-related potentials in different subtypes of multiple sclerosis - a cross -sectional study. J Neurol Sci 2002; 15: 35-40.

30. Casanova-Gonzales MF, Cabrera-Gomez JA, Aquino-Cais J, Aneiro Rivas R, Fernandes-Bermudez R. Neurophysiological assesment in patients with clinically defined multiple sclerosis with special reference to P300 wave study. Rev Neurol 1999; 29: 1134-1137.

31. Gil R, Zai L, Neau JP, Jonveaux T, Agbo C, Rosolacci T et al. Event-related auditory potentials and multiple sclerosis. Electroencephalogr Clin Neurophysiol 1993; 88: 182-7.

32. Giesser BS, Schroeder MM, LaRocca NG, Kutzberg D, Ritter W, Vaughan HG et al. Endogenous event-related potentials as indices of dementia in multiple sclerosis patients. Electroencephalogr Clin Neurophysiol 1992; 85: 320-329.

33. Ruchkin DS, Grafman J, Krauss GL, Johnson RJr, Canoune H, Ritter W. Event-related brain potential evidence for a verbal working memory deficit in multiple sclerosis. Brain 1994; 117: 289-305.

34. Camp SJ, Stevenson VL, Thompson AJ, Miller DH, Borras C, Auriacombe S, Brochet B et al. Cognitive function in primary progressive and transitional progressive multiple sclerosis: a controlled study with MRI correlates. Brain 1999; 122: 1341-1348.

35. Grigsby J, Ayarbe SD, Kravcisin A, Busenbark D. Working memory impairment among persons with chronic progressive multiple sclerosis. J. Neurol 1994; 241: 125-131.

36. Javurková A. Neuropsychologické vyšetření u pacientu s roztroušeou sklerózou. Československá psychologie 2001, 3: 22-26.

37. Brázdil M, Dobšík M, Pažourková M, Krupa P, Rektor I. Význam funkční magnetické rezonance pro hodnocení kognitivních pochodu v lidském mozku. Lokalizace „oddball“ úkolem aktivovaných neuronálních populací. Cesk Slov Neurol N 66/99; 2003; 1: 20-30.

38. Staffen W, Mair A, Zauner H, Unterrainer J, Niederhofer H, Kutzelnigg A et al. Cognitive function and fMRI in patients with multiple sclerosis: evidence for compensatory cortical activation during an attention task. Brain 2002; 125: 1275-1282.

39. Beatty WW, Goodkin DE, Hertsgaard D, Monson N. Clinical and demographic predictors of cognitive performance in multiple sclerosis: Do diagnostic type, disease duration, and disability matter? Arch Neurol 1990; 47: 305-308.

40. Klonoff H, Clark C, Oger J, Paty D, Li D. Neuropsychological performance in patients with mild multiple sclerosis. J Nerv Ment Dis 1991; 179: 127-131.

41. Rao SM, Leo GJ, Bernardin L, Unverzagt F. Cognitive dysfunction in multiple sclerosis: I. Frequency, patterns, and prediction. Neurology, 41: 685-691.

42. Krokavcová M, Gavelová M, Nagyová I, Gdovinová Z, van Dijk JP, Middel B et al. Self-rated health in patients with different forms of multiple sclerosis: preliminary results. Eur J Public Health 2004; 14: 96.

43. Drobný M, Bartko D, Kurča E, Šútorová D, Michalik J, Voško MR, Krátky M a kol. Sclerosis multiplex. Martin: Reklas 2002.

44. Maurelli M, Marchioni E, Cerretano R, Bosone D, Bergamaschi R, Citterio A et al. Neuropsychological assessment in MS: clinical, neuropsychological and neuroradiological relationships. Acta Neurol Scand 1992; 86: 124-128.

45. Millefiorini E, Padovani A, Pozzilli C, Loriedo C, Bastianello S, Buttinelli C et al. Depression in the early phase of MS: Influence of functional disability, cognitive impairment and brain abnormalities. Acta Neurol Scand 1992; 86: 354-358.

46. Moller A, Wiedemann G, Rohde U, Backmund H, Sontag A. Correlates of cognitive impairment and depressive mood disorder in multiple sclerosis. Acta Psych Scand 1994; 89: 117-121.

47. Sládková V, Muchová B, Ticháčková A, Mareš J, Urbánek K, Kaňovský P. Výskyt depresí u nemocných s roztroušenou sklerózou mozkomíšní. Cesk Slov Neurol N 2006; 69/102: 280-285.

48. Amato MP, Ponziani G, Siracusa G, Sorbi S. Cognitive dysfunction in early-onset multiple sclerosis: a reappraisal after 10 years. Arch Neurol 2001; 10: 1602-1606.

49. Rao SM, Leo GJ, Ellington L, Nauertz T, Bernardin L, Unverzagt F. Cognitive dysfunction in multiple sclerosis. II. Impact on employment and social functioning. Neurology 1991; 41: 692-696.